Prilenia Therapeutics is a clinical stage biotech company developing its lead drug candidate, pridopidine, for Huntington’s Disease and ALS. It was founded in 2018 with the purpose of improving the lives of patients and their families by developing treatments for neurodegenerative and neurodevelopmental disorders.
No open positions at the moment
Browse all jobs